| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.79 | 0.002 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.73 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.3 |